Ministry of Welfare, Celltrion, Daewoong, Celid, Ubio, etc.

Input 2021.01.26 15:19 | Revision 2021.01.26 16:59

Corona 19 treatment/vaccine clinical support 3rd project selection result

The Ministry of Health and Welfare’s Central Accident Control Headquarters announced on the 26th that it will additionally support clinical trials at 4 vaccine developers for the novel coronavirus infection (Corona 19). The cure is Celltrion (068270)and Daewoong Pharmaceutical (069620), The vaccine is with Celide Ubiologics (206650)Has been selected.

The Ministry of Health and Welfare is calling for clinical support projects every other month through the National New Drug Development Project. In the third project, a total of 10 drugs were applied, and 4 of them were selected.

Celltrion will receive extended support for phase 1 and 2 of the existing antibody treatments to phase 3, and Daewoong Pharmaceutical will receive new support for Camostat following the existing niclosamide. Celid and Ubiologics each receive Phase 1 and 2 support for vaccine candidates. As a result, the Ministry of Health and Welfare will spend a total of 120.8 billion won to support clinical trials of a total of 10 drugs (5 treatments and 5 vaccines).

The Ministry of Health and Welfare is helping companies to quickly complete recruitment of test subjects through the National Infectious Disease Clinical Trial Center as well as financial support.